Clinical Trial Update: Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating tumor-associated antigen-specific T cells (TAA-T) in combination with a PD-1 inhibitor for Hodgkin lymphoma and diffuse lar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Hodgkin Lymphoma

Drugs mentioned

• Tumor-associated antigen-specific T cells (TAA-T) with PD-1 inhibitor

Snippet

Sponsor: Catherine Bollard | Conditions: Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING